Tokyo, June 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058214) titled 'The clinical significance of NT-proBNP measurement in patients undergoing hemodialysis' on June 30.
Study Type:
Observational
Primary Sponsor:
Institute - Fujita Memorial Hospital
Condition:
Condition - Hemodialysis patents
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the clinical significance of NT-proBNP in determining dry weight and assessing myocardial status in patients undergoing hemodialysis.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - Patients undergoing maintenanc...